PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107

• Uri Ilan,
• Judith M. Boer,
• Birgit Burkhardt,
• Frederik van Delft,
• Shai Izraeli,
• Jan-Henning Klusmann,
• Barbara De Moerloose,
• Pablo Velasco,
• Julie Irving,
• José Luis Fuster,
• Dániel Erdélyi,
• Andreas E Kulozik,
• Dirk Reinhardt,
• Michel Zwaan,
• Monique L. den Boer

Affiliations

Uri Ilan

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Judith M. Boer

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Birgit Burkhardt

2 Münster University Hospital, Münster, Germany

Frederik van Delft

3 Newcastle University Centre for Cancer, Newcastle, United Kingdom

Shai Izraeli

4 Schneider- Children’s Medical Center, Petah Tikva, Israel

Jan-Henning Klusmann

5 Goethe University Frankfurt, Frankfurt, Germany

Barbara De Moerloose

6 Universiteit Gent - Campus Dunant, Gent, Belgium

Pablo Velasco

7 La Vall d’Hebron, Barcelona, Spain

Julie Irving

8 Newcastle University, Translational and Clinical Research Institute, Newcastle, United Kingdom

José Luis Fuster

9 Virgen De La Arrixaca, Murcia, Spain

Dániel Erdélyi

10 Semmelweis University, Budapest, Hungary

Andreas E Kulozik

11 University Hospital Heidelberg, Heidelberg, Germany

Dirk Reinhardt

12 University of Duisburg-Essen, Essen, Germany

Michel Zwaan

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Monique L. den Boer

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands